149 related articles for article (PubMed ID: 20535151)
1. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
2. Expression of IGFBP7 in acute leukemia is regulated by DNA methylation.
Heesch S; Bartram I; Neumann M; Reins J; Mossner M; Schlee C; Stroux A; Haferlach T; Goekbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Cancer Sci; 2011 Jan; 102(1):253-9. PubMed ID: 21040219
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
5. shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells.
Xu B; Chen G; Shi P; Guo X; Xiao P; Wang W; Zhou S
Hematology; 2012 Jan; 17(1):35-40. PubMed ID: 22549446
[TBL] [Abstract][Full Text] [Related]
6. Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia.
Hu S; Chen R; Man X; Feng X; Cen J; Gu W; He H; Li J; Chai Y; Chen Z
Pediatr Hematol Oncol; 2011 May; 28(4):279-87. PubMed ID: 21413833
[TBL] [Abstract][Full Text] [Related]
7. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.
Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G
J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499
[TBL] [Abstract][Full Text] [Related]
8. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
9. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667
[TBL] [Abstract][Full Text] [Related]
10. BAALC, a novel marker of human hematopoietic progenitor cells.
Baldus CD; Tanner SM; Kusewitt DF; Liyanarachchi S; Choi C; Caligiuri MA; Bloomfield CD; de la Chapelle A
Exp Hematol; 2003 Nov; 31(11):1051-6. PubMed ID: 14585369
[TBL] [Abstract][Full Text] [Related]
11. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase.
Laranjeira AB; de Vasconcellos JF; Sodek L; Spago MC; Fornazim MC; Tone LG; Brandalise SR; Nowill AE; Yunes JA
Leukemia; 2012 May; 26(5):1001-11. PubMed ID: 22005787
[TBL] [Abstract][Full Text] [Related]
12. Histone post-translational modifications associated to BAALC expression in leukemic cells.
Franzoni A; Passon N; Fabbro D; Tiribelli M; Damiani D; Damante G
Biochem Biophys Res Commun; 2012 Jan; 417(2):721-5. PubMed ID: 22197554
[TBL] [Abstract][Full Text] [Related]
13. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia.
Kühnl A; Gökbuget N; Stroux A; Burmeister T; Neumann M; Heesch S; Haferlach T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood; 2010 May; 115(18):3737-44. PubMed ID: 20065290
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization.
Heesch S; Neumann M; Schwartz S; Bartram I; Schlee C; Burmeister T; Hänel M; Ganser A; Heuser M; Wendtner CM; Berdel WE; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Ann Hematol; 2013 Jun; 92(6):747-58. PubMed ID: 23412561
[TBL] [Abstract][Full Text] [Related]
15. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
Santamaría C; Chillón MC; García-Sanz R; Pérez C; Caballero MD; Mateos MV; Ramos F; de Coca AG; Alonso JM; Giraldo P; Bernal T; Queizán JA; Rodríguez JN; Puig N; Balanzategui A; Sarasquete ME; Alcoceba M; Díaz-Mediavilla J; San Miguel J; González M
Ann Hematol; 2010 May; 89(5):453-8. PubMed ID: 19943049
[TBL] [Abstract][Full Text] [Related]
16. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
17. BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Schwind S; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Becker H; Whitman SP; Wu YZ; Metzeler KH; Powell BL; Kolitz JE; Carter TH; Moore JO; Baer MR; Carroll AJ; Caligiuri MA; Larson RA; Bloomfield CD
Blood; 2010 Dec; 116(25):5660-9. PubMed ID: 20841507
[TBL] [Abstract][Full Text] [Related]
18. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
[TBL] [Abstract][Full Text] [Related]
19. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
20. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
Akahane K; Inukai T; Zhang X; Hirose K; Kuroda I; Goi K; Honna H; Kagami K; Nakazawa S; Endo K; Kubota T; Yagita H; Koyama-Okazaki T; Sugita K
Exp Hematol; 2010 Oct; 38(10):885-95. PubMed ID: 20670671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
